We are live on ! Find out more
WS

Wedbush Securities Portfolio holdings

AUM $3.43B
1-Year Est. Return 24.13%
This Fund
S&P 500
This Quarter Est. Return
+1.08%
1 Year Est. Return
+24.13%
3 Year Est. Return
+79.76%
5 Year Est. Return
+94.69%
10 Year Est. Return
+325.94%
AUM
$1.02B
AUM Growth
+$27.5M
Cap. Flow
+$25.3M
Cap. Flow %
2.48%
Top 10 Hldgs %
15.83%
Holding
1,066
New
79
Increased
466
Reduced
323
Closed
88

Sector Composition

Rank Sector Weight
1 Technology 12.81%
2 Financials 9.1%
3 Healthcare 8.59%
4 Consumer Discretionary 8.14%
5 Industrials 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TARA icon
926
Protara Therapeutics
TARA
$226M
$43K ﹤0.01%
4,162
+1,562
+60% +$22.4K
CALA
927
DELISTED
Calithera Biosciences, Inc
CALA
$42K ﹤0.01%
+675
New +$54K
LUMO
928
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$41K ﹤0.01%
+2,841
New +$41.7K
CLSD
929
DELISTED
Clearside Biomedical
CLSD
$39K ﹤0.01%
4,093
+26
+0.6% +$373
GASS icon
930
StealthGas
GASS
$328M
$39K ﹤0.01%
12,850
-3,000
-19% -$10.2K
NSPR icon
931
InspireMD
NSPR
$32M
$39K ﹤0.01%
+2,000
New +$80.8K
UAN icon
932
CVR Partners
UAN
$1.3B
$39K ﹤0.01%
1,013
VTVT icon
933
vTv Therapeutics
VTVT
$121M
$39K ﹤0.01%
+628
New +$35.5K
KDNY
934
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$39K ﹤0.01%
+7,400
New +$49.1K
CETX icon
935
Cemtrex
CETX
$4.65M
0
DVAX
936
DELISTED
Dynavax Technologies
DVAX
$38K ﹤0.01%
10,500
CHK
937
DELISTED
Chesapeake Energy Corporation
CHK
$36K ﹤0.01%
129
+8
+7% +$2.6K
FTFT icon
938
Future FinTech Group
FTFT
$2.2M
$35K ﹤0.01%
+53
New +$43.3K
NBEV
939
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$35K ﹤0.01%
12,700
+2,000
+19% +$7.06K
INO icon
940
Inovio Pharmaceuticals
INO
$79.8M
$34K ﹤0.01%
+1,375
New +$41.8K
JAGX icon
941
Jaguar Health
JAGX
$4.73M
0
CPAH
942
DELISTED
Counterpath Corp
CPAH
$32K ﹤0.01%
28,192
+11,874
+73% +$15.7K
PLX icon
943
Protalix BioTherapeutics
PLX
$191M
$30K ﹤0.01%
14,500
+6,000
+71% +$17.9K
RGLS
944
DELISTED
Regulus Therapeutics
RGLS
$30K ﹤0.01%
4,117
+779
+23% +$6.34K
EFOI icon
945
Energy Focus
EFOI
$18.3M
$29K ﹤0.01%
1,743
HCR
946
DELISTED
Hi-Crush Inc. Common Stock
HCR
$26K ﹤0.01%
14,895
-5,800
-28% -$11.1K
CCM
947
Concord Medical Services
CCM
$18.7M
$25K ﹤0.01%
1,072
-1,050
-49% -$26.7K
GPUS
948
Hyperscale Data Inc
GPUS
$57.8M
0
VLRX
949
DELISTED
VALERITAS HOLDINGS INC
VLRX
$23K ﹤0.01%
+16,391
New +$38K
IBIO icon
950
iBio
IBIO
$71M
$21K ﹤0.01%
79
+39
+98% +$13.1K

Similar funds

Wedbush Securities's Q3 2019 Portfolio in Review

As of Q3 2019, Wedbush Securities held 1,066 positions worth $1.02B, up 2.8% from $995M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Wedbush Securities's Q3 2019 filing shows 79 new, 466 increased, 323 reduced and 88 closed positions. Its largest new stake was Vanguard World Funds Extended Duration ETF: 13,668 shares worth $1.93M. The largest sale was PAR Technology, an estimated $1.39M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

  • Wedbush Securities's largest Q3 2019 buy was Vanguard World Funds Extended Duration ETF: 13,668 shares worth $1.93M.
  • Wedbush Securities added most to iShares 0-1 Year Treasury Bond ETF in Q3 2019, an estimated $2.17M increase.
  • Wedbush Securities's biggest Q3 2019 reduction was PAR Technology, cutting an estimated $1.39M.
  • Wedbush Securities fully exited EMC INS Group Inc in Q3 2019, selling an estimated $793K.
  • Wedbush Securities's ten largest holdings make up 16% of its $1.02B portfolio in Q3 2019.
  • Wedbush Securities opened 79 new positions and closed 88 in Q3 2019.
  • Wedbush Securities's portfolio value rose 2.8% quarter-over-quarter to $1.02B.

Based on Wedbush Securities's 13F filing for Q3 2019, filed 17 Oct 2019.